TABLE 3.
Effect of clinical background against the presence of viral RNA in saliva of 88 symptomatic patients
| Parameter | Presence of viral RNA in saliva |
P valuea | |
|---|---|---|---|
| Positive (n = 74) | Negative (n = 14) | ||
| Median age (yr) of subjects with indicated test result (IQR) | 46 (38–60) | 44 (37–53) | 0.344 |
| No. (%) of subjects with indicated test result/total who were: | |||
| Male (n = 59) | 54/59 (91.5) | 5/59 (8.5) | 0.011 |
| Female (n = 29) | 20/29 (69.0) | 9/29 (31.0) | |
| No. (%) of subjects with indicated test result/total with disease severity: | |||
| Mild (n = 72) | 58/72 (80.6) | 14/72 (19.4) | 0.064 |
| Severe (n = 16) | 16/16 (100) | ||
| No. (%) of subjects with indicated test result/total with clinical symptom: | |||
| Fever (n =73) | 62/73 (84.9) | 11/73 (15.1) | 0.700 |
| Cough (n = 45) | 41/45 (91.1) | 4/45 (8.9) | 0.084 |
| Malaise (n = 30) | 25/30 (83.3) | 5/30 (16.7) | 1.000 |
| Headache (n = 25) | 22/25 (88.0) | 3/25 (12.0) | 0.749 |
| Diarrhea (n = 20) | 15/20 (75.0) | 5/20 (25.0) | 0.294 |
| Sore throat (n = 19) | 15/19 (78.9) | 4/19 (21.1) | 0.491 |
| Tachypnea (n = 13) | 13/13 (100) | 0.117 | |
| Dyspnea (n = 8) | 8/8 (100) | 0.346 | |
| Hypoxemia (SpO2 < 93%) (n = 10) | 10/10 (100) | 0.353 | |
a
The P value was calculated using the Wilcoxon rank sum test for continuous variables and the χ2 test or Fisher’s exact test for categorical variables.